The software can diagnose chest x-rays as normal, according to the vendor. Behold.ai estimates that the ability to rule out normal exams could save an estimated 100 million pounds (114.8 million euros) in costs each year for the U.K. National Health Service (NHS). In addition, it means that the company's red dot platform can be utilized to speed up detection of COVID-19 patients, Behold.ai said.
The CE Mark was issued by the British Standards Institute and related to the full quality assurance system for Behold.ai's AI technology and to the design, development, and manufacture of its red dot platform, the company said.
Copyright © 2020 AuntMinnieEurope.com